{"id":"https://openalex.org/W7203962041","doi":null,"title":"Exploring Novel B-cell Specific Immunomodulatory Adjuvants and Future Implications for HIV Vaccines","display_name":"Exploring Novel B-cell Specific Immunomodulatory Adjuvants and Future Implications for HIV Vaccines","publication_year":2026,"publication_date":"2026-06-01","ids":{"openalex":"https://openalex.org/W7203962041"},"language":"en","primary_location":{"id":"pmh:oai:utoronto.scholaris.ca:1807/153568","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/1807/153568","pdf_url":null,"source":{"id":"https://openalex.org/S4306400261","display_name":"TSpace (University of Toronto)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I185261750","host_organization_name":"University of Toronto","host_organization_lineage":["https://openalex.org/I185261750"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Thesis"},"volume":null,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://hdl.handle.net/1807/153568","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5147734806","display_name":"Tiantian Zhao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Zhao, Tiantian","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5147734806"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9897000193595886,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.004800000227987766,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10835","display_name":"Carbohydrate Chemistry and Synthesis","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-1-vaccine","display_name":"HIV-1 vaccine","score":0.7990000247955322},{"id":"https://openalex.org/keywords/broadly-neutralizing-antibodies","display_name":"broadly neutralizing antibodies","score":0.9850000143051147},{"id":"https://openalex.org/keywords/hiv-1-envelope-glycoprotein","display_name":"HIV-1 envelope glycoprotein","score":0.75},{"id":"https://openalex.org/keywords/bg505-sosip-664","display_name":"BG505 SOSIP.664","score":0.9539999961853027},{"id":"https://openalex.org/keywords/protein-nanoparticles","display_name":"protein nanoparticles","score":0.8240000009536743},{"id":"https://openalex.org/keywords/cd19","display_name":"CD19","score":0.7149999737739563},{"id":"https://openalex.org/keywords/b-cell-activation","display_name":"B cell activation","score":0.5860000252723694},{"id":"https://openalex.org/keywords/vrc01","display_name":"VRC01","score":0.8069999814033508},{"id":"https://openalex.org/keywords/b-cell-receptor-signaling","display_name":"B cell receptor signaling","score":0.609000027179718},{"id":"https://openalex.org/keywords/t-follicular-helper-cells","display_name":"T follicular helper cells","score":0.8029999732971191},{"id":"https://openalex.org/keywords/hiv-1-env-trimer","display_name":"HIV-1 Env trimer","score":0.4580000042915344}],"concepts":[{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.6875},{"id":"https://openalex.org/C2780115692","wikidata":"https://www.wikidata.org/wiki/Q5747302","display_name":"Heterologous","level":3,"score":0.5314000248908997},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5264999866485596},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4803999960422516},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.4366999864578247},{"id":"https://openalex.org/C2778957590","wikidata":"https://www.wikidata.org/wiki/Q798033","display_name":"CD19","level":3,"score":0.4302999973297119},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4239000082015991},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.40529999136924744},{"id":"https://openalex.org/C108625454","wikidata":"https://www.wikidata.org/wiki/Q187126","display_name":"Glycoprotein","level":2,"score":0.4043999910354614},{"id":"https://openalex.org/C2776258796","wikidata":"https://www.wikidata.org/wiki/Q5590520","display_name":"Gp41","level":4,"score":0.3986000120639801},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.37549999356269836},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.36250001192092896},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.3619999885559082},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.3619000017642975},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.36010000109672546},{"id":"https://openalex.org/C109825262","wikidata":"https://www.wikidata.org/wiki/Q1139164","display_name":"Germline","level":3,"score":0.32839998602867126},{"id":"https://openalex.org/C2780195530","wikidata":"https://www.wikidata.org/wiki/Q1479804","display_name":"HIV vaccine","level":4,"score":0.32519999146461487},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.31700000166893005},{"id":"https://openalex.org/C97380033","wikidata":"https://www.wikidata.org/wiki/Q994215","display_name":"Viral envelope","level":3,"score":0.31700000166893005},{"id":"https://openalex.org/C51639874","wikidata":"https://www.wikidata.org/wiki/Q167149","display_name":"Plasma protein binding","level":2,"score":0.30959999561309814},{"id":"https://openalex.org/C174510640","wikidata":"https://www.wikidata.org/wiki/Q489618","display_name":"HEK 293 cells","level":3,"score":0.3012999892234802},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.2800999879837036},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.2773999869823456},{"id":"https://openalex.org/C2909828532","wikidata":"https://www.wikidata.org/wiki/Q1479804","display_name":"AIDS Vaccines","level":4,"score":0.2685000002384186},{"id":"https://openalex.org/C54009773","wikidata":"https://www.wikidata.org/wiki/Q1429031","display_name":"Transfection","level":3,"score":0.26109999418258667},{"id":"https://openalex.org/C2779690655","wikidata":"https://www.wikidata.org/wiki/Q374232","display_name":"Lentivirus","level":4,"score":0.259799987077713},{"id":"https://openalex.org/C147816474","wikidata":"https://www.wikidata.org/wiki/Q169525","display_name":"Protein engineering","level":3,"score":0.25589999556541443}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:utoronto.scholaris.ca:1807/153568","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/1807/153568","pdf_url":null,"source":{"id":"https://openalex.org/S4306400261","display_name":"TSpace (University of Toronto)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I185261750","host_organization_name":"University of Toronto","host_organization_lineage":["https://openalex.org/I185261750"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Thesis"}],"best_oa_location":{"id":"pmh:oai:utoronto.scholaris.ca:1807/153568","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/1807/153568","pdf_url":null,"source":{"id":"https://openalex.org/S4306400261","display_name":"TSpace (University of Toronto)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I185261750","host_organization_name":"University of Toronto","host_organization_lineage":["https://openalex.org/I185261750"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Thesis"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2965498567","https://openalex.org/W4306811590","https://openalex.org/W1706743371","https://openalex.org/W4410455565","https://openalex.org/W2052937459","https://openalex.org/W4399180501","https://openalex.org/W2320044375","https://openalex.org/W7140286164","https://openalex.org/W2158417216","https://openalex.org/W3173771166"],"abstract_inverted_index":{"Eliciting":[0],"broadly":[1],"neutralizing":[2,283],"antibodies":[3,273,281],"(bNAbs)":[4],"against":[5,53],"human":[6],"immunodeficiency":[7],"virus-1":[8],"(HIV-1).":[9],"HIV-1":[10,48,311,339],"infects":[11],"CD4":[12],"T":[13,267],"cells":[14,100,129],"through":[15],"its":[16,136],"envelope":[17],"glycoprotein":[18],"trimer":[19],"(Env),":[20],"which":[21,157],"is":[22,312],"the":[23,29,82,102,260,285,293,316],"only":[24,256],"virally":[25],"encoded":[26],"protein":[27,118,162],"on":[28,161,223,315],"viral":[30],"surface":[31],"and":[32,67,85,135,176,190,194,235,265,335,340],"thus":[33],"serves":[34],"as":[35,120,310],"a":[36,121,131,148,152,209,301],"key":[37,153],"target":[38],"for":[39,93,124,338],"vaccine":[40,122],"development.":[41],"By":[42],"binding":[43],"to":[44,97,126,241,276,284,295],"conserved":[45],"epitopes":[46,92],"of":[47,56,105,144,167,174,318,323],"Env,":[49],"bNAbs":[50,109],"confer":[51],"protection":[52],"multiple":[54],"clades":[55],"HIV-1.":[57],"To":[58],"elicit":[59,108],"bNAbs,":[60,94,106],"engineered":[61],"Env":[62,70,78,221,243],"proteins":[63],"that":[64,142,171,217,297],"are":[65,71,76],"stable":[66],"mimic":[68,86],"native":[69,87,242],"required.":[72],"BG505":[73,95,125,277,288],"SOSIP.664":[74],"(BG505)":[75],"recombinant":[77],"trimers":[79],"locked":[80],"in":[81,110,183,208,245,330],"pre-fusion":[83],"conformation":[84],"Env.":[88],"Despite":[89],"displaying":[90,233],"many":[91],"failed":[96],"activate":[98,127],"B":[99,128,154,180],"expressing":[101,130],"germline":[103,137],"precursor":[104,138],"or":[107],"mouse":[111,212],"models.":[112],"In":[113,252],"this":[114],"study":[115,291,326],"we":[116,215],"tested":[117],"nanoparticles":[119,163,225,232],"platform":[123],"potent":[132],"bNAb,":[133],"VRC01":[134],"(gVRC01).":[139],"We":[140,169],"hypothesized":[141],"presentation":[143],"BG505,":[145],"together":[146],"with":[147,238,305],"CD19":[149,177,189,255,319],"targeting":[150],"antibody,":[151],"cell":[155,181],"coreceptor":[156],"enhances":[158],"BCR":[159],"signaling,":[160],"would":[164],"enhance":[165],"activation":[166,200],"gVRC01-BCR.":[168],"found":[170,216],"nanoparticle-mediated":[172],"co-engagement":[173],"VRC01-BCR":[175],"synergistically":[178],"enhanced":[179,199,226],"signaling":[182],"vitro,":[184],"including":[185],"elevated":[186],"calcium":[187],"flux,":[188],"total":[191],"tyrosine":[192],"phosphorylation,":[193],"downstream":[195],"signaling.":[196,228],"Notably,":[197],"such":[198,309],"did":[201],"not":[202,250],"translate":[203],"into":[204],"increased":[205,246,266],"Env-specific":[206,247],"IgG":[207,264],"wild":[210],"type":[211],"model.":[213],"However,":[214],"incorporating":[218],"germline-targeting":[219],"(GT)":[220],"variants":[222,237],"anti-CD19-Fab-incorporated":[224],"gVRC01-BCR":[227],"Heterologous":[229],"immunizations":[230],"using":[231],"anti-CD19":[234],"GT-Env":[236],"increasing":[239],"resemblance":[240],"resulted":[244],"IgM":[248],"but":[249],"IgG.":[251],"contrast,":[253],"engaging":[254],"during":[257,300],"prime":[258],"polarized":[259],"immune":[261],"response":[262],"towards":[263],"follicular":[268],"helper":[269],"cells.":[270],"Although":[271],"these":[272],"were":[274,282],"non-neutralizing":[275],"pseudoviruses":[278],"(PsV),":[279],"elicited":[280],"near-native":[286],"N276D":[287],"PsV.":[289],"Our":[290],"was":[292],"first":[294],"demonstrate":[296],"antibody":[298],"responses":[299],"multi-dosage":[302],"immunization":[303,336],"regimen":[304],"low":[306],"affinity":[307],"antigen":[308],"highly":[313],"dependent":[314],"timing":[317],"co-engagement.":[320],"The":[321],"findings":[322],"our":[324],"current":[325],"could":[327],"be":[328],"instructive":[329],"guiding":[331],"future":[332],"immunogen":[333],"designs":[334],"strategies":[337],"other":[341],"infectious":[342],"agents.":[343]},"counts_by_year":[],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2026-08-22T00:00:00"}